$114.88
+0.65 (+0.57%)
Last updated: Jul 15, 2026 02:28
Fundamentals Overview
Incyte Corporation is near the high of its 52-week range with attractive valuation, trading relatively flat today.
Valuation attractive
Intrinsic value (DCF)
+6.4% upside vs price
Profitability
Risk (Beta)
0.76 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Analyst grade: A+ · 3M vs S&P 500: +10.7% · 3M vs Healthcare sector: +13.3%
Pressures (Sell):
Sentiment weakening (2 downgrades)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A+. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 13, Equal Weight: 3, Hold: 2, In Line: 1, Market Perform: 2, Neutral: 2, Overweight: 4, Perform: 1, Sector Perform: 2.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $122.27; current price is $114.88. That’s a +6.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 16.6 |
| DCF value (model) | $122.27 (6.4% upside) |
| PEG (TTM) | 0 |
| P/B (TTM) | 4.12 |
| P/S (TTM) | 4.28 |
| P/FCF (TTM) | 15.82 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 3.68 |
| Quick Ratio (TTM) | 3.6 |
| Cash Ratio (TTM) | 2.32 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 26.71% |
| Gross margin (TTM) | 92.48% |
| Operating margin (TTM) | 27.05% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for INCY.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Barclays | maintain | Overweight | Overweight | 2026-07-14 |
| BMO Capital | maintain | Market Perform | Market Perform | 2026-07-13 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2026-07-07 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-06-29 |
| UBS | maintain | Neutral | Neutral | 2026-06-26 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-06-24 |
| Truist Securities | maintain | Hold | Hold | 2026-06-22 |
| BMO Capital | upgrade | Underperform | Market Perform | 2026-06-22 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-06-09 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-05-21 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-05-04 |
| Stifel | maintain | Buy | Buy | 2026-04-29 |
| Oppenheimer | maintain | Perform | Perform | 2026-04-29 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-04-15 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-03-30 |
| UBS | maintain | Neutral | Neutral | 2026-03-25 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-03-25 |
| Jefferies | downgrade | Buy | Hold | 2026-03-16 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-03-09 |
| Evercore ISI Group | maintain | In Line | In Line | 2026-03-05 |
| Barclays | maintain | Overweight | Overweight | 2026-02-18 |
| Stifel | maintain | Buy | Buy | 2026-02-11 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-02-11 |
| RBC Capital | maintain | Sector Perform | Sector Perform | 2026-02-11 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-02-11 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-02-06 |
| Barclays | maintain | Overweight | Overweight | 2026-02-04 |
| Wells Fargo | downgrade | Overweight | Equal Weight | 2026-01-20 |
| TD Cowen | maintain | Buy | Buy | 2026-01-13 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-01-06 |